Riskpilot← Back to searchSign inGet full accessOPHTHALMOS AS
ASActiveOrg 912748162Valkendorfsgaten 5, 5012 BergenMedical specialists activities · NACE 8622Est. 20132 employees
Revenue 2024
NOK 12M
+4% vs 2023
EBITDA margin
31.2%
+12% vs 2023
Equity ratio
74.9%
Financial strength
Net profit 2024
NOK 3,2M
+12% vs 2023
| Revenue | NOK 12M | +4% |
| EBITDA | NOK 3,7M | +12% |
| Net profit | NOK 3,2M | +12% |
| Total assets | NOK 10,7M | +17% |
| Equity | NOK 8M | +26% |
| Employees | 2 | — |
Legal name
OPHTHALMOS AS
Org number
912748162
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. november 2013
Share capital
NOK 60 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive øyelegevirksomhet
Address
Valkendorfsgaten 5, 5012 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 510 | 9 399 | 9 466 | 11 555 | 12 007 |
| Staff expenses | −1 340 | −1 377 | −1 404 | −1 831 | −1 918 |
| EBITDA | 2 725 | 3 415 | 2 808 | 3 336 | 3 748 |
| Depreciation & amort. | −285 | −84 | −71 | −38 | −10 |
| EBIT | 2 440 | 3 332 | 2 737 | 3 299 | 3 737 |
| Net financials | 14 | 109 | 843 | 291 | 315 |
| Profit before tax | 2 453 | 3 441 | 3 580 | 3 590 | 4 053 |
| Tax | 540 | 736 | 619 | 768 | 886 |
| Net profit | 1 913 | 2 705 | 2 961 | 2 822 | 3 166 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 978 | 6 859 | 7 693 | 9 152 | 10 706 |
| Equity | 4 067 | 3 572 | 5 033 | 6 355 | 8 021 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 911 | 3 287 | 2 660 | 2 797 | 2 684 |
| Total debt | 2 911 | 3 287 | 2 660 | 2 797 | 2 684 |
EBITDA margin
31.2%
This company
15.8%
Market median
+97% vs market
20202024
Equity ratio
74.9%
This company
38.2%
Market median
+96% vs market
20202024
Return on equity
39.5%
This company
18.4%
Market median
+115% vs market
20202024
Net profit margin
26.4%
This company
8.1%
Market median
+226% vs market
20202024
Asset turnover
1.12×
This company
1.12×
Market median
+0% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
OK Chief Executive Officer | Chief Executive Officer | 2013 |
SH Deputy Member | Deputy Member | 2013 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OPHTHALMOS AS 
Bergen Øyelegesenter AsBoard members of OPHTHALMOS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Kjeka | Chief Executive Officer | 0 companies |
| Sæbjørg Hageberg Kjeka | Deputy Member | 0 companies |